|
|
|
40
|
0131U
|
ZITHROMAX 40MG/ML SUSP (PFI/STO) AZITHROMYCIN
|
AZITHROMYCIN
|
ZITHROMAX
|
15ML
|
C
|
29.66
|
1.98
|
SUSPENSION
|
0
|
ML
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
08121292
|
OTHER MACROLIDES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
0131U
|
ZITHROMAX 40MG/ML SUSP (PFI) AZITHRO (C)
|
AZITHROMYCIN
|
ZITHROMAX
|
15ML
|
C
|
29.96
|
1.9971
|
ML
|
30
|
BOTT
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
08121292
|
OTHER MACROLIDES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
OTHER MACROLIDES
|
|
|
|
|
42
|
0131U
|
ZITHROMAX 40MG/ML SUSP (PFI) AZITHR
|
AZITHROMYCIN
|
ZITHROMAX
|
15ML
|
C
|
29.96
|
2.00
|
ML
|
30
|
BOTT
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
B
|
08121292
|
OTHER MACROLIDES
|
2026-04-01
|
|
|
ORAL
|
0
|
OTHER MACROLIDES
|
|
|
|
|
40
|
0141AH
|
ZITHROMAX 500MG TAB (PFI/STO) AZITHROMYCIN
|
AZITHROMYCIN
|
ZITHROMAX
|
3'S
|
C
|
53.01
|
17.67
|
TABLET
|
0
|
TAB
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
08121292
|
OTHER MACROLIDES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
0141AH
|
ZITHROMAX 500MG TAB (PFI) AZITHROMY (C)
|
AZITHROMYCIN
|
ZITHROMAX
|
3'S
|
C
|
53.52
|
17.8413
|
TAB
|
7
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
08121292
|
OTHER MACROLIDES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
OTHER MACROLIDES
|
|
|
|
|
42
|
0141AH
|
ZITHROMAX 500MG TAB (PFI) AZITHROMY
|
AZITHROMYCIN
|
ZITHROMAX
|
3'S
|
C
|
53.52
|
17.84
|
TAB
|
10
|
BLIS
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
08121292
|
OTHER MACROLIDES
|
2026-04-01
|
|
|
ORAL
|
0
|
OTHER MACROLIDES
|
|
|
|
|
40
|
0211AG
|
MERREM 500MG INJ (PFI/STO) MEROPENEM
|
MEROPENEM
|
MERREM
|
10X500MG
|
C
|
561.20
|
56.12
|
INJECTION
|
0
|
VIAL
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
08120708
|
CARBAPENEMS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
0212BE
|
MERREM 1G INJ (PFI/STO) MEROPENEM
|
MEROPENEM
|
MERREM
|
10X1G
|
C
|
968.73
|
96.87
|
INJECTION
|
0
|
VIAL
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
08120708
|
CARBAPENEMS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
0212BE
|
MERREM 1G INJ (PFI) MEROPENEM (C)
|
MEROPENEM
|
MERREM
|
10X1G
|
C
|
879.6
|
87.9595
|
VIAL
|
42
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
08120708
|
CARBAPENEMS
|
2024-04-01
|
2026-03-31
|
|
IV
|
2
|
CARBAPENEMS
|
|
|
|
|
40
|
04612
|
SALAZOPYRINE E.C. 500MG TAB (PFI/STO) SULPHAS
|
SULPHASALAZINE
|
SALAZOPYRINE E.C.
|
100'S
|
C
|
70.24
|
0.70
|
TABLET
|
0
|
TAB
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
081220
|
SULPHONAMIDES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
04612
|
SALAZOPYRINE E.C. 500MG TAB (PFI) SULPHA (C)
|
SULPHASALAZINE
|
SALAZOPYRINE E.C.
|
100'S
|
C
|
70.95
|
0.7095
|
TAB
|
240
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
081220
|
SULPHONAMIDES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
SULPHONAMIDES
|
|
|
|
|
42
|
04612
|
SALAZOPYRIN 500MG TAB (PFI) SULPHASALAZINE
|
SULPHASALAZINE
|
SALAZOPYRIN
|
100'S
|
C
|
70.95
|
0.71
|
TAB
|
240
|
BLIS
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
081220
|
SULPHONAMIDES
|
2026-04-01
|
|
|
ORAL
|
6
|
SULPHONAMIDES
|
|
|
|
|
40
|
1131CZ
|
LIPITOR 10MG TAB (PFI/STO) ATORVASTATIN
|
ATORVASTATIN
|
LIPITOR
|
30'S
|
C
|
33.19
|
1.11
|
TABLET
|
0
|
TAB
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
1131CZ
|
LIPITOR 10MG TAB (PFI) ATORVASTATIN (C)
|
ATORVASTATIN
|
LIPITOR
|
30'S
|
C
|
33.49
|
1.1163
|
TAB
|
30
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
|
|
|
|
40
|
1131DA
|
LIPITOR 10MG TAB (PFI/SBI) ATORVASTATIN
|
ATORVASTATIN
|
LIPITOR
|
30'S
|
C
|
33.19
|
1.11
|
TABLET
|
0
|
TAB
|
PFI
|
PFIZER CORPORATION
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
1131DA
|
LIPITOR 10MG TAB (PFI) ATORVASTATIN (C)
|
ATORVASTATIN
|
LIPITOR
|
30'S
|
C
|
33.49
|
1.1163
|
TAB
|
30
|
BOX
|
PFI
|
PFIZER CORPORATION
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
|
|
|
|
42
|
1131GX
|
LIPITOR 10MG TAB (PFI) ATORVASTATI (C)
|
ATORVASTATIN
|
LIPITOR
|
3X10
|
C
|
33.49
|
1.12
|
TAB
|
30
|
BLIS
|
PFI
|
PFIZER CORPORATION
|
COL
|
AVENTA BARBADOS
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2026-04-01
|
|
|
ORAL
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
|
|
|
|
40
|
1132DV
|
LIPITOR 20MG TAB (PFI/STO) ATORVASTATIN
|
ATORVASTATIN
|
LIPITOR
|
30'S
|
C
|
36.21
|
1.21
|
TABLET
|
0
|
TAB
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
1132DV
|
LIPITOR 20MG TAB (PFI) ATORVASTATIN (C)
|
ATORVASTATIN
|
LIPITOR
|
30'S
|
C
|
36.53
|
1.2178
|
TAB
|
30
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
|
|
|
|
40
|
1132DW
|
LIPITOR 20MG TAB (PFI/SBI) ATORVASTATIN
|
ATORVASTATIN
|
LIPITOR
|
30'S
|
C
|
36.21
|
1.21
|
TABLET
|
0
|
TAB
|
PFI
|
PFIZER CORPORATION
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CARDIOVASCULAR DRUGS
|
|